Latest gastrointestinal News | Page 9

AGA Journals’ Impact Factors released: TIGE receives first Impact Factor
Imfinzi plus Imjudo demonstrated sustained overall survival benefit in advanced liver cancer with an unprecedented one in four patients alive at four…
Scientists identify common cause of gastro in young children and adults over 50 years old
Profitable by-products from shellfish waste
Stomal Therapy Week at Mater
Profound health impacts of violence
Dr. Kara Marshall joins the Pew Scholars Program in the Biomedical Sciences
American Gastroenterological Association and American College of Gastroenterology and invest in Oshi Health to accelerate adoption of hybrid digestive health care
Do you need to wash rice before cooking? Here’s the science
Anatara Lifesciences updates on GaRP irritable bowel syndrome trial
Shedding Light on the Complex Flow Dynamics within the Small Intestine
Why does my dog eat grass? And when is it not safe for them?
Elizabeth Johnson wins inaugural Schwartz visionary grant
UHC offers to trade GI prior auth for a poorly defined alternative
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Shining light on ‘lesser known’ disability
ACG and AGA Guideline on Chronic Constipation Management is First to Recommend Supplements Magnesium Oxide and Senna as Evidence-Based Treatments
Forensics are different when someone dies in a body of water. First, you need to locate them
UNE poultry scientist awarded ARC Early Career Industry Fell
Dr. Kara Marshall named HHMI Freeman Hrabowski Scholar
Clinicians must look beyond physical symptoms to care for people with deep-seated trauma
Artificial intelligence to predict chemotherapy toxicities in colon cancer patients
Time is running out: patients, physicians brace for anticipated delays, denials by UnitedHealthcare for endoscopies starting June 1
Time is running out: patients, physicians brace for anticipated delays, denials by UnitedHealthcare for endoscopies starting June 1
NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of…
World-first app helps shift workers get more and better sleep
Largest medical research grant to help ME/CFS and Long COVID research
Dung testing predicts diet quality for better herd and land management
Poisonous mushrooms warning issued for Victoria
JAKAVI® NOW LISTED ON THE PBS FOR PATIENTS AGED 12 YEARS AND OLDER WITH ACUTE OR CHRONIC GvHD
New Health Tech Innovation Centre Opens In Melbourne
ANDHealth CHICC Opening
Gut to be good for you: FODMAP cookbook will improve millions of lives
World-leading Monash team produces its first FODMAP cookbook
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks
WHO releases priorities for research and development of age-appropriate antibiotics
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
Lone star tick bites may be to blame for unexplained digestive problems
10 things you probably didn’t know about dietitians
??10 things you probably didn’t know about dietitians?
Chimeric Therapeutics advances manufacture of CHM 2101 viral vector
First the floods, then the diseases — why NZ should brace for outbreaks of spillover infections from animals
Human norovirus GII.4 exploits unexpected entry mechanism to cause gastroenteritis
HMRI Poo Palace puts digestive issues conversation on menu
3D bioprinting inside the human body could be possible thanks to new soft robot
Food coloring, anti-caking nanoparticles may affect human gut
Limited Ozempic supplies to commence distribution in Australia